T Shoji, H Koyama, T Morioka, S Tanaka, A Kizu, K … - Diabetes, 2006 - Am Diabetes Assoc Angiogenic response is impaired in diabetes. Here, we examined the involvement of receptor
for advanced glycation end products (RAGE) in diabetes-related impairment of angiogenesis
in vivo. Angiogenesis was determined in reconstituted basement membrane protein ( ... Cited by 27 - Related articles - BL Direct - All 5 versions
N Katakami, M Matsuhisa, H Kaneto, Y Yamasaki - Atherosclerosis, 2007 - Elsevier In patients with type 2 diabetes, atherosclerotic diseases lead to the impairment of quality of life
and are major causes of mortality. Advanced glycation end-products (AGE) and their receptor
(the receptor for AGE, RAGE) system, which is accelerated in diabetes, plays an important ... Cited by 12 - Related articles - All 19 versions
XH Guo, QB Huang, B Chen, SY Wang, Q Li, YJ … - APMIS- …, 2006 - jpkc.fimmu.com Departments of 1Pathophysiology, 2Key Lab for Shock and Microcirculation Research, 3Nephrology
(Nanfang Hospital), 4Immunology, Southern Medical University, Guangzhou, PR China, and
5Division of Pharmacology, Faculty of Health Sciences, Linkoping University, Linkoping, ... Cited by 8 - Related articles - View as HTML - BL Direct - All 6 versions
- ►diabetesjournals.org KM Myint, Y Yamamoto, T Doi, I Kato, A Harashima, H … - Diabetes, 2006 - Am Diabetes Assoc Diabetic nephropathy is a major microvascular complication in long-standing diabetic patients
who eventually undergo renal dialysis or transplantation. To prevent development of this disease
and to improve advanced kidney injury, effective therapies directed toward the key ... Cited by 35 - Related articles - BL Direct - All 6 versions
KCB Tan, SWM Shiu, WS Chow, L Leng, R Bucala, DJ … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis Activation of the receptor for advanced glycation end products
(RAGE, also known as AGE- specific receptor [AGER]) has been implicated in the development
of diabetic vascular complications. Blockade of RAGE using a soluble form of the receptor ... Cited by 39 - Related articles - All 5 versions
H Koyama, T Shoji, S Fukumoto, K Shinohara, … - … and Vascular Biology, 2007 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... Low Circulating Endogenous Secretory Receptor for AGEs Cited by 32 - Related articles - All 7 versions
PM Humpert, Z Djuric, S Kopf, G Rudofsky, M … - Cardiovascular …, 2007 - cardiab.com In bivariate analysis, sRAGE correlated with age (R = 0.22, p = 0.02) and the 24 hour albumin
excretion rate (R = 0.18, p = 0.05), while esRAGE correlated positively with age only (R =
0.23, p = 0.02). In contrast to previous reports, neither sRAGE nor esRAGE correlated with ... Cited by 47 - Related articles - Cached - All 10 versions
S Sakurai, Y Yamamoto, H Tamei, H Matsuki, K … - Diabetes research and …, 2006 - Elsevier We recently identified a naturally occurring soluble form of RAGE (the receptor for advanced
glycation endproducts, receptor for AGE) in cultured human vascular cells, and named it endogenous
secretory RAGE (esRAGE). esRAGE is generated by alternative RNA splicing and is able ... Cited by 33 - Related articles - All 10 versions
- ►clinchem.org [PDF] M Challier, S Jacqueminet, O Benabdesselam, A … - Clinical …, 2005 - Am Assoc Clin Chem To the Editor: The hyperglycemic state occurring in diabetes mellitus is responsible for formation
and accumulation of advanced glycation endproducts (AGEs) that participate in the pathogenesis
of vascular complica- tions of diabetes mellitus (1). There is considerable interest in the ... Cited by 18 - Related articles - BL Direct - All 3 versions
